• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经皮腔内血管成形术后再狭窄：临床、生理及病理特征

Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.

作者信息

Cox J L, Gotlieb A I

出版信息

CMAJ. 1986 May 15;134(10):1129-32.

PMID:2938706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1491035/
Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has been used clinically for 8 years and is becoming widely accepted in the treatment of atherosclerotic coronary artery disease. Since the long-term effects of the procedure are unknown, the rate of restenosis following the procedure, approximately 30%, is of major concern. We briefly review the current status of PTCA and the effect of angioplasty on the vessel wall and discuss proposed mechanisms of recurrent stenosis.

摘要

经皮腔内冠状动脉成形术（PTCA）已临床应用8年，在治疗动脉粥样硬化性冠状动脉疾病方面正被广泛接受。由于该手术的长期效果尚不清楚，术后再狭窄率约为30%，这是主要关注的问题。我们简要回顾PTCA的现状以及血管成形术对血管壁的影响，并讨论复发性狭窄的可能机制。

相似文献

1
Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.经皮腔内血管成形术后再狭窄：临床、生理及病理特征
CMAJ. 1986 May 15;134(10):1129-32.
2
Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty.临床成功进行冠状动脉球囊血管成形术后晚期（超过30天）的形态学观察。
Circulation. 1991 Feb;83(2 Suppl):I28-41.
3
[Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].[冠状动脉血管成形术后复发性狭窄。临床、细胞生物学及分子学方面]
Z Kardiol. 1995 Jan;84(1):5-21.
4
[Restenosis after coronary angioplasty: its pathogenesis and prevention].[冠状动脉血管成形术后再狭窄：其发病机制与预防]
Cardiologia. 1991 Dec;36(12 Suppl 1):309-20.
5
[Gene therapy for the treatment of restenosis after coronary angioplasty].[基因治疗用于冠状动脉成形术后再狭窄的治疗]
Cardiologia. 1994 Dec;39(12):843-7.
6
Restenosis following coronary artery angioplasty: patterns, recognition, and results of repeat angioplasty.冠状动脉血管成形术后再狭窄：模式、识别及再次血管成形术的结果
Cardiovasc Clin. 1988;19(2):233-51.
7
The paradigm of restenosis following percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后再狭窄的范例。
Eur Heart J. 1993 Nov;14 Suppl I:187-92.
8
Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty.冠状动脉成形术后再狭窄发生过程中的血小板-血管壁相互作用。
Z Kardiol. 1987;76 Suppl 6:23-8.
9
Restenosis after percutaneous transluminal coronary angioplasty: new therapeutic insights from pathogenic mechanisms.经皮腔内冠状动脉成形术后再狭窄：致病机制的新治疗见解
Adv Intern Med. 1995;40:445-501.
10
[Long-term prognosis in patients with single-vessel or double-vessel coronary artery disease: does successful revascularization achieved by coronary angioplasty improve late outcome?].[单支或双支冠状动脉疾病患者的长期预后：冠状动脉成形术实现的成功血运重建能否改善晚期结局？]
J Cardiol. 2003 Jul;42(1):1-11.

引用本文的文献

1
Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries. An update.使用铱 - 192高剂量率近距离治疗预防外周动脉再狭窄。最新进展。
Herz. 1998 Sep;23(6):394-400. doi: 10.1007/BF03043605.
2
[Endovascular Ir-192 HDR brachytherapy for avoidance of intimal hyperplasia in peripheral vessels after PTA and stent implantation. A 6-year experience].[血管内铱-192高剂量率近距离放射治疗预防经皮腔内血管成形术和支架植入术后外周血管内膜增生。六年经验]
Strahlenther Onkol. 1998 Mar;174(3):115-20. doi: 10.1007/BF03038493.
3
Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents.用可弯曲钽支架治疗髂股和股腘血管闭塞性疾病。
Cardiovasc Intervent Radiol. 1993 May-Jun;16(3):158-64. doi: 10.1007/BF02641885.
4
The Strecker stent: indications and results in iliac and femoropopliteal arteries.施特雷克支架：髂动脉和股腘动脉的适应症及治疗结果
Cardiovasc Intervent Radiol. 1992 Sep-Oct;15(5):298-305. doi: 10.1007/BF02733954.

本文引用的文献

1
The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients.256例未经手术治疗患者冠状动脉造影显示的冠状动脉疾病解剖学演变。
Circulation. 1981 Mar;63(3):527-36. doi: 10.1161/01.cir.63.3.527.
2
The mechanism of balloon angioplasty.球囊血管成形术的机制。
Radiology. 1980 Jun;135(3):565-71. doi: 10.1148/radiology.135.3.7384437.
3
Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.腔内血管成形术：实验模型中形态学与血管造影结果的相关性
Circulation. 1980 Apr;61(4):778-85. doi: 10.1161/01.cir.61.4.778.
4
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival.兔新生内膜损伤后的凝血酶生成与纤维蛋白形成。血管壁反应性及血小板存活情况研究。
Lab Invest. 1982 Jun;46(6):605-12.
5
Smooth muscle and endothelial cell function in the pathogenesis of atherosclerosis.平滑肌和内皮细胞功能在动脉粥样硬化发病机制中的作用
Can Med Assoc J. 1982 Apr 15;126(8):903-8.
6
Blood velocity in the right coronary artery: relation to the distribution of atherosclerotic lesions.右冠状动脉中的血流速度：与动脉粥样硬化病变分布的关系。
Am J Cardiol. 1984 Apr 1;53(8):1008-12. doi: 10.1016/0002-9149(84)90627-1.
7
Acute effects of transluminal angioplasty in three experimental models of atherosclerosis.经皮腔内血管成形术在三种动脉粥样硬化实验模型中的急性效应。
Arteriosclerosis. 1982 Mar-Apr;2(2):125-33. doi: 10.1161/01.atv.2.2.125.
8
Pathological findings after percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后的病理结果。
Br Heart J. 1984 Nov;52(5):588-90. doi: 10.1136/hrt.52.5.588.
9
Determinants of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung, and Blood Institute Registry.经皮腔内冠状动脉成形术成功的决定因素：美国国立心肺血液研究所登记报告
Am Heart J. 1984 Oct;108(4 Pt 1):1019-23. doi: 10.1016/0002-8703(84)90470-8.
10
Transluminal angioplasty: a mechanical-pathophysiological correlation of its physical mechanisms.腔内血管成形术：其物理机制的机械-病理生理相关性
Radiology. 1984 Oct;153(1):85-9. doi: 10.1148/radiology.153.1.6236478.